- Home
- BODI vs JUNS Comparison
BODI vs JUNS Comparison
Compare BODI & JUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- JUNS
- Stock Information
- Founded
- BODI 1998
- JUNS 2015
- Country
- BODI United States
- JUNS United States
- Employees
- BODI N/A
- JUNS N/A
- Industry
- BODI Industrial Machinery/Components
- JUNS
- Sector
- BODI Industrials
- JUNS
- Exchange
- BODI Nasdaq
- JUNS NYSE
- Market Cap
- BODI 25.4M
- JUNS 20.5M
- IPO Year
- BODI N/A
- JUNS 2024
- Fundamental
- Price
- BODI $4.15
- JUNS $2.37
- Analyst Decision
- BODI Strong Buy
- JUNS
- Analyst Count
- BODI 3
- JUNS 0
- Target Price
- BODI $10.67
- JUNS N/A
- AVG Volume (30 Days)
- BODI 23.6K
- JUNS 723.2K
- Earning Date
- BODI 08-05-2025
- JUNS 08-11-2025
- Dividend Yield
- BODI N/A
- JUNS N/A
- EPS Growth
- BODI N/A
- JUNS N/A
- EPS
- BODI N/A
- JUNS N/A
- Revenue
- BODI $371,113,000.00
- JUNS N/A
- Revenue This Year
- BODI N/A
- JUNS N/A
- Revenue Next Year
- BODI N/A
- JUNS N/A
- P/E Ratio
- BODI N/A
- JUNS N/A
- Revenue Growth
- BODI N/A
- JUNS N/A
- 52 Week Low
- BODI $3.38
- JUNS $0.51
- 52 Week High
- BODI $8.71
- JUNS $19.51
- Technical
- Relative Strength Index (RSI)
- BODI 50.21
- JUNS N/A
- Support Level
- BODI $3.75
- JUNS N/A
- Resistance Level
- BODI $4.43
- JUNS N/A
- Average True Range (ATR)
- BODI 0.28
- JUNS 0.00
- MACD
- BODI 0.03
- JUNS 0.00
- Stochastic Oscillator
- BODI 53.31
- JUNS 0.00
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About JUNS JUPITER NEUROSCIENCES INC
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.